Hudson Bay Capital Management LP

10% OwnerAkers Biosciences, Inc. (AKER) · full profile →Form 4 · filed Jan 7, 2020
Net Buying
Open-Market Buys
$556K
Open-Market Sells
$0
Net Open-Market Flow
$556K
Transactions
12
12 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 20, 2019Buy(P)8K$3.02$24K269K
Dec 19, 2019Buy(P)3K$3.08$8K261K
Dec 18, 2019Buy(P)8K$3.07$23K258K
Dec 17, 2019Buy(P)3K$3.03$9K251K
Dec 16, 2019Buy(P)5K$3.07$15K248K
Dec 13, 2019Buy(P)6K$3.02$18K243K
Dec 12, 2019Buy(P)21K$2.98$61K237K
Dec 11, 2019Buy(P)6K$3.05$18K216K
Dec 11, 2019Buy(P)26K$3.10$82K210K
Dec 10, 2019Buy(P)30K$2.97$89K184K
Dec 9, 2019Buy(P)19K$2.96$57K104K
Dec 9, 2019Buy(P)50K$2.99$150K154K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001393825-20-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about AKER insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001393825-20-000002"
Ask your agent
Use Arkolith to summarize insider buying and selling at Akers Biosciences, Inc.
over the last 90 days and cite the filings.